Skip to main content
68th Annual Scientific Meeting Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Red Recording
Red Recording
Sig Meeting
Sig Meeting

Therapeutics (Industry)

(T 3) TRPM8 Channel Blockade with Elismetrep in a Phase 2B study: A Novel Approach for Treating Migraine

    Presenting Author(s)

  • BL

    Brett Lauring, MD, PhD

    Chief Medical Officer
    Kallyope, Inc.
    New York, NY, United States

    • Non-presenting Author(s)

  • Peter Goadsby, PhD DSc FRACP FRCP FMedSci FRS

    Professor of Neurology and Honorary Consultant Neurologist
    University of Leeds UK, King Abdullah University of Science and Technology, Saudi Arabia,NIHR King’s Clinical Research Facility, & SLaM Biomedical Research Centre, and The Wolfson Sensory, Pain and Regeneration Centre (SPaRC), Institute of Psychiatry, Psychology and Neuroscience, King’s College London, UK
    London, United Kingdom

  • NS

    Nicolas P. Saikali, MD, NBPAS, FAHS

    Director of Headache Fellowship Board Certified in Neurology, Neuroimaging, and Headache Medicine
    Dent Neurologic Institute
    Amherst, New York, United States

  • AA

    Anna Arreglado, M.D.

    Head, Data Management
    Kallyope, Inc., United States

  • JL

    Jiajun Liu, Ph.D.

    VP, Biometrics
    Kallyope, Inc., United States

  • AV

    Annemarie Vance, M.S.

    VP, Clinical Operations
    Kallyope, Inc, United States

  • HZ

    Hong Zhang, M.S.

    Head, Statistical Programming
    Kallyope, Inc, United States

  • MC

    Michael F. Crutchlow, MD

    VP Translational Medicine
    Kallyope, Inc.
    New York, NY, United States